Skip to content
Clinical Trial Events
DIA Europe

Talk Clinical Trials Innovation track

S0101 - The Right Future Model for Europe: CTR and How to Move Forward (Including X-Border Trials)

Tue, Mar 18, 2025 · 1:30–2:40 PM CET Singapore Room, Congress Center Basel

About this session

This session will review the latest developments on the clinical trial ecosystem in Europe, including implementation of CTR, and projects such as CTR collaborate as well as the cross-border initiative. The multistakeholder panel discussion will discuss what the clinical trial ecosystem of the future should look like and identify together with the audience bold ideas that can make Europe unique, break the current barriers, simplify and harmonise.

Programme:
- 2. CTR Collaborate - A CTCG Project to Discuss and Optimize Procedures in the Member State Review of Clinical Trial Applications — Ann Marie Janson Lang
- 4. Enabling Cross Border Access to Clinical Trials — Susan Bhatti
- 1. Clinical Trials Regulation 2.0: For Patients, For Researchers, For Europe — Martin O'Kane
- 3. MedEthicsEU: Collaboration of Medical Research Ethics Committees — Monique Al
- Panel Discussion — Nikos Dedes, Isabelle Clamou, Monique Al

Speakers

  • Nikos Dedes

    General Secretary · Greek Patients Association

    Panelist

  • Isabelle Clamou

    Policy Officer, DG SANTE Unit D2 · European Commission

    Panelist

  • Ann Marie Janson Lang

    Expert, Assoc Prof · Swedish Medical Products Agency

    Speaker

  • Monique Al

    Special advisor sr · CCMO, Then Netherlands

    Speaker

  • Susan Bhatti

    Director EU Global Regulatory and Scientific Policy, Global Regulatory Affairs · Merck BV

    Speaker

  • Martin O'Kane

    Regional Head Regulatory Affairs EU Policy & Liaison · Novartis

    Speaker

  • Lada Leyens

    Senior Director regulatory · Takeda

    Chair

  • Marianne Lunzer

    CTCG Chair · AGES MEA

    Chair